Cargando…

Rheumatic Symptoms Following Coronavirus Disease 2019 (COVID-19): A Chronic Post–COVID-19 Condition

BACKGROUND: Detailed characteristics of rheumatic symptoms of coronavirus disease 2019 (COVID-19) were still unknown. We aim to investigate the proportions, characteristics, and risk factors of this condition. METHODS: In this prospective, longitudinal cohort study, discharged patients with COVID-19...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cui, Dan, Wang, Yeming, Huang, Lixue, Gu, Xiaoying, Huang, Zhisheng, Mu, Shengrui, Wang, Chen, Cao, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992351/ https://www.ncbi.nlm.nih.gov/pubmed/35611349 http://dx.doi.org/10.1093/ofid/ofac170

Ejemplares similares

Long-term effects of COVID-19 on kidney function – Authors' reply
por: Huang, Lixue, et al.
Publicado: (2021)

Evolution of Coronavirus Disease 2019 (COVID-19) Symptoms During the First 12 Months After Illness Onset
por: Wynberg, Elke, et al.
Publicado: (2021)

Cluster of coronavirus disease 2019 (Covid-19) in the French Alps, 2020
por: Danis, Kostas, et al.
Publicado: (2020)

Prospective Evaluation of Coronavirus Disease 2019 (COVID-19) Vaccine Responses Across a Broad Spectrum of Immunocompromising Conditions: the COVID-19 Vaccination in the Immunocompromised Study (COVICS)
por: Haidar, Ghady, et al.
Publicado: (2022)

Population Attributable Fractions of Underlying Medical Conditions for Coronavirus Disease 2019 (COVID-19) Diagnosis and COVID-19 Hospitalizations, Ventilations, and Deaths Among Adults in the United States
por: Nguyen, Jennifer L, et al.
Publicado: (2022)

Prevalence of and Factors Associated With Post-Coronavirus Disease 2019 (COVID-19) Condition in the 12 Months After the Diagnosis of COVID-19 in Adults Followed in General Practices in Germany
por: Kostev, Karel, et al.
Publicado: (2022)

Comparative Effectiveness of Coronavirus Disease 2019 (COVID-19) Vaccines Against the Delta Variant
por: Risk, Malcolm, et al.
Publicado: (2022)

Impact of the Coronavirus Disease 2019 (COVID-19) Vaccine on Asymptomatic Infection Among Patients Undergoing Preprocedural COVID-19 Molecular Screening
por: Tande, Aaron J, et al.
Publicado: (2021)

Coronavirus disease 2019 (COVID-19) and anti-rheumatic drugs
por: Georgiev, Tsvetoslav
Publicado: (2020)

Real-World Experience of Bamlanivimab for Coronavirus Disease 2019 (COVID-19): A Case-Control Study
por: Kumar, Rebecca N, et al.
Publicado: (2021)

The Impact of Vaccination on Coronavirus Disease 2019 (COVID-19) Outbreaks in the United States
por: Moghadas, Seyed M, et al.
Publicado: (2021)

Association of acute kidney injury with 1-year outcome of kidney function in hospital survivors with COVID-19: A cohort study
por: Gu, Xiaoying, et al.
Publicado: (2022)

Compassionate Use of REGEN-COV(®) in Patients With Coronavirus Disease 2019 (COVID-19) and Immunodeficiency-Associated Antibody Disorders
por: Stein, David, et al.
Publicado: (2021)

High Mortality During the Second Wave of the Coronavirus Disease 2019 (COVID-19) Pandemic in Uganda: Experience From a National Referral COVID-19 Treatment Unit
por: Bongomin, Felix, et al.
Publicado: (2021)

The Efficacy and Safety of Janus Kinase Inhibitors for Patients With COVID-19: A Living Systematic Review and Meta-Analysis
por: Zhang, Xueyang, et al.
Publicado: (2022)

The US Coronavirus Disease 2019 (COVID-19) Surveillance Environment: An Ecological Analysis of the Relationship of Testing Adequacy in the Context of Vaccination
por: Choi, Daesung, et al.
Publicado: (2022)

The Protective Effect of Coronavirus Disease 2019 (COVID-19) Vaccination on Postacute Sequelae of COVID-19: A Multicenter Study From a Large National Health Research Network
por: Zisis, Sokratis N, et al.
Publicado: (2022)

Low-to-moderate dose corticosteroids treatment in hospitalized adults with COVID-19
por: Liu, Zhibo, et al.
Publicado: (2021)

Effectiveness of Coronavirus Disease 2019 (COVID-19) Vaccines Among Incarcerated People in California State Prisons: Retrospective Cohort Study
por: Chin, Elizabeth T, et al.
Publicado: (2022)

Symptoms of COVID-19 Outpatients in the United States
por: Pullen, Matthew F, et al.
Publicado: (2020)

Differential Patterns by Area-Level Social Determinants of Health in Coronavirus Disease 2019 (COVID-19)–Related Mortality and Non–COVID-19 Mortality: A Population-Based Study of 11.8 Million People in Ontario, Canada
por: Wang, Linwei, et al.
Publicado: (2022)

Absence of nosocomial transmission of coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 in the prepandemic phase in Hong Kong
por: Cheng, Vincent C.C., et al.
Publicado: (2020)

Coronavirus disease 2019 (COVID-19) during pregnancy in patients with rheumatic diseases
por: Boyadzhieva, Vladimira Vasileva, et al.
Publicado: (2020)

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)–Specific T Cells and Antibodies in Coronavirus Disease 2019 (COVID-19) Protection: A Prospective Study( )
por: Molodtsov, Ivan A, et al.
Publicado: (2022)

Persistent Symptoms and Association With Inflammatory Cytokine Signatures in Recovered Coronavirus Disease 2019 Patients
por: Ong, Sean Wei Xiang, et al.
Publicado: (2021)

Projected Long-Term Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Hepatitis C Outcomes in the United States: A Modeling Study
por: Barocas, Joshua A, et al.
Publicado: (2021)

Correlates of Coronavirus Disease 2019 (COVID-19) Vaccine Hesitancy Among People Who Inject Drugs in the San Diego-Tijuana Border Region
por: Strathdee, Steffanie A, et al.
Publicado: (2021)

Propensity-Score Matched Analysis of the Effectiveness of Baricitinib in Patients With Coronavirus Disease 2019 (COVID-19) Using Nationwide Real-World Data: An Observational Matched Cohort Study From the Japan COVID-19 Task Force
por: Tanaka, Hiromu, et al.
Publicado: (2023)

Prevention of Coronavirus Disease 2019 (COVID-19) by mRNA-Based Vaccines Within the General Population of California
por: Andrejko, Kristin L, et al.
Publicado: (2021)

Risk Factors for Infection and Health Impacts of the Coronavirus Disease 2019 (COVID-19) Pandemic in People With Autoimmune Diseases
por: Fitzgerald, Kathryn C, et al.
Publicado: (2021)

Mathematical Modeling to Inform Vaccination Strategies and Testing Approaches for Coronavirus Disease 2019 (COVID-19) in Nursing Homes
por: Kahn, Rebecca, et al.
Publicado: (2021)

Measuring Vaccine Efficacy Against Infection and Disease in Clinical Trials: Sources and Magnitude of Bias in Coronavirus Disease 2019 (COVID-19) Vaccine Efficacy Estimates
por: Williams, Lucy R, et al.
Publicado: (2021)

Potential Effects of the Coronavirus Disease 2019 (COVID-19) Pandemic on Human Immunodeficiency Virus (HIV) Transmission: A Modeling Study in 32 US Cities
por: Fojo, Anthony, et al.
Publicado: (2022)

Long-term effects on survivors with COVID-19 – Authors' reply
por: Huang, Lixue, et al.
Publicado: (2021)

Plasma Metabolomic Profiling of Patients Recovered From Coronavirus Disease 2019 (COVID-19) With Pulmonary Sequelae 3 Months After Discharge
por: Xu, Juanjuan, et al.
Publicado: (2021)

Persistent Symptoms in Patients Recovering From COVID-19 in Denmark
por: Leth, Steffen, et al.
Publicado: (2021)

Clinical characteristics and symptom duration among outpatients with COVID-19
por: Lane, Alexandra, et al.
Publicado: (2022)

Novel coronavirus disease-2019 (COVID-19) in people with rheumatic disease: Epidemiology and outcomes
por: Grainger, Rebecca, et al.
Publicado: (2021)

Twelve-Month Systemic Consequences of Coronavirus Disease 2019 (COVID-19) in Patients Discharged From Hospital: A Prospective Cohort Study in Wuhan, China
por: Liu, Tingting, et al.
Publicado: (2021)

A glimpse into long COVID and symptoms – Authors' reply
por: Huang, Lixue, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r39rfffr5dn4c8i5lspjft1p5j